Opinion statement
Patients with acoustic neuromas have several treatment options that include observation, surgical resection, stereotactic radiosurgery, and fractionated radiotherapy. Resection is indicated for patients with larger tumors that have caused major neurologic deficits from brain compression. Surgeons perform stereotactic radiosurgery as the main alternative to acoustic tumor resection with the goals of preserved neurologic function and prevention of tumor growth. The long-term outcomes of radiosurgery, particularly with gamma knife technique, have proven its role in the primary or adjuvant management of this disease. Radiotherapy can be offered to selected patients with larger tumors in whom radiosurgery may not be feasible. Patients with neurofibromatosis type-2 pose specific challenges, particularly in regard to preservation of hearing and other cranial nerve function. The primary clinical issues include avoiding tumor-related or treatment-related mortality, prevention of further tumor-related neurologic disability, minimizing treatment risks such as spinal fluid leakage, infections, or cardiopulmonary complications, maintaining regional cranial nerve function (facial, trigeminal, cochlear, and glossopharyngeal/vagal), avoiding hydrocephalus, maintaining quality of life and employment, and reducing cost. All treatment choices should strive to meet all of these goals.
Similar content being viewed by others
References and Recommended Reading
House JW, Brackmann DE: Facial nerve grading system. Otolaryngol Head Neck Surg 1985, 93:146–147.
Gardner G, Robertson JH: Hearing preservation in unilateral acoustic neuroma surgery. Ann Otol Rhinol Laryngol 1988, 97:55–66.
Kondziolka D, Dempsey PK, Lunsford LD, et al.: A comparison between magnetic resonance imaging and computed tomography for stereotactic coordinate determination. Neurosurgery 1992, 30:402–407.
Flickinger JC, Lunsford LD, Wu A, et al.: Treatment planning for gamma knife radiosurgery with multiple isocenters. Int J Radiat Oncol Biol Phys 1990, 18:1495–1501.
Norén G, Arndt J, Hindmarsh T: Stereotactic radiosurgery in cases of acoustic neurinoma: further experiences. Neurosurgery 1983, 13:12–22.
Flickinger JC, Kondziolka D, Niranjan A, Lunsford LD: Results of acoustic neuroma radiosurgery: an analysis of 5 years experience using current methods. J Neurosurg 2001, 94:1–6. A comprehensive analysis of radiosurgery using current techniques, with extensive follow-up.
Linskey ME, Lunsford LD, Flickinger JC: Neuroimaging of acoustic nerve sheath tumors after stereotaxic radiosurgery. AJNR 1991, 12:1165–1175.
Kondziolka D, Lunsford LD, McLaughlin M, et al.: Long-term outcomes after acoustic tumor radiosurgery: the physicians and patients perspective. N Engl J Med 1998, 339:1426–1433. This report represents a series of consecutive patients with the longest follow-up, including information on patient-reported outcomes and patient satisfaction.
Flickinger JC, Kondziolka D, Lunsford LD, et al.: Evolution in technique for vestibular schwannoma radiosurgery and effect on outcome. Int J Radiat Oncol Biol Phys 1996, 36:275–280.
Subach B, Kondziolka D, Lunsford LD, et al.: Stereotactic radiosurgery in the management of acoustic neuromas associated with neurofibromatosis—type II. J Neurosurg 1999, 90:815–822. Most complete analysis following radiosurgery for patients with neurofibromatosis type 2.
Linskey M, Lunsford LD, Flickinger JC: Tumor control after stereotactic radiosurgery in neurofibromatosis patients with bilateral acoustic tumors. Neurosurgery 1992, 31:829–832.
Wiegand DA, Fickel V. Acoustic neuroma—the patient’s perspective: subjective assessment of symptoms, diagnosis, therapy, and outcome in 541 patients. Laryngoscope 1989, 99:179–187.
Wiegand DA, Ojemann R, Fickel V: Surgical treatment of acoustic neuroma (vestibular schwannoma) in the United States: report from the Acoustic Neuroma Registry. Laryngoscope 1996, 106:58–66.
SamiiM, Matthies C: Management of 1000 vestibular schwannomas (acoustic neuromas): surgical management and results with an emphasis on complications and how to avoid them. Neurosurgery 1997, 40:11–23. A comprehensive analysis of results following surgical resection, from one of the largest surgical series.
Gormley WB, Sekhar LN, Wright D, et al.: Acoustic neuromas: results of current surgical management. Neurosurgery 1997, 41:50–60. Recent review of a large surgical series using modern techniques.
Pollock BE, Lunsford LD, Kondziolka D, et al.: Outcome analysis of acoustic neuroma management: a comparison of microsurgery and stereotactic radiosurgery. Neurosurgery 1995, 36:215–229.
Cerullo LJ, Grutsch JF, Heiferman K, et al.: The preservation of hearing and facial nerve function in a consecutive series of unilateral vestibular nerve schwannoma surgical patients. Surg Neurol 1993, 39:485–493.
Mazzoni A, Calabrese V, Moschini L: Residual and recurrent acoustic neuroma in hearing preservation procedures: neuroradiologic and surgical findings. Skull Base Surg 1996, 6:105–112.
Post KD, Eisenberg MB, Catalano PJ: Hearing preservation in vestibular schwannoma surgery: what factors influence outcome? J Neurosurg 1995, 83:191–196.
Pollock B, Lunsford LD, Flickinger J, et al.: Vestibular schwannoma management: part I. Failed microsurgery and the role of delayed stereotactic radiosurgery. J Neurosurg 1998, 89:944–948.
Pollock B, Lunsford LD, Kondziolka D, et al.: Vestibular schwannoma management: part II. Failed radiosurgery and the role of delayed microsurgery. J Neurosurg 1998, 89:949–955.
Linskey ME, Martinez AS, Kondziolka D, et al.: The radiobiology of human acoustic schwannoma xenografts after stereotactic radiosurgery evaluated in the subrenal capsule of athymic mice. J Neurosurg 1993, 78:645–653.
Rowed DW Nedzelski JM: Hearing preservation in the removal of intracanalicular acoustic neuromas via the retrosigmoid approach. J Neurosurg 1997, 86:456–461.
Bederson JB, von Ammon K, Wichmann W, et al.: Conservative treatment of patients with acoustic tumors. Neurosurgery 1991, 28:646–651.
Samii M, Tatagiba M, Matthies C: Acoustic neurinoma in the elderly: factors predictive of postoperative outcome. Neurosurgery 1992, 31:615–620.
Yamamoto M, Hagiwara S, Ide M, et al.: Conservative management of acoustic neurinomas: prospective study of long-term changes in tumor volume and auditory function. Min Invasiv Neurosurg 1998, 41:86–92.
Foote RL, Coffey RJ, Swanson J, et al.: Stereotactic radiosurgery using the gamma knife for acoustic neuromas. Int J Radiat Oncol Biol Phys 1995, 32:1153–1160.
Flickinger JC, Kondziolka D, Lunsford LD: Dose and diameter relationships for facial, trigeminal, and acoustic neuropathies following acoustic neuroma radiosurgery. Radiother Oncol 1996, 41:215–219.
Flickinger JC, Lunsford LD, Linskey ME, et al.: Gamma knife radiosurgery for acoustic tumors: multivariate analysis of four year results. Radiother Oncol 1993, 27:91–98.
Ogunrinde OK, Lunsford LD, Flickinger JC, Kondziolka D: Cranial nerve preservation after stereotactic radiosurgery of small acoustic tumors. Arch Neurol 1995, 52:73–79.
Ogunrinde OK, Lunsford LD, Flickinger JC, et al.: Stereotactic radiosurgery for acoustic tumors in patients with useful preoperative hearing: results at two years. J Neurosurg 1994, 80:1011–1017.
Williams JA: “Fractionated stereotactic radiotherapy for acoustic neurons”. Presented at the Meeting of the Congress of Neurological Surgeons; San Antonio, TX; October 2001.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kondziolka, D., Lunsford, L.D. & Flickinger, J.C. Acoustic neuromas. Curr Treat Options Neurol 4, 157–165 (2002). https://doi.org/10.1007/s11940-002-0024-2
Issue Date:
DOI: https://doi.org/10.1007/s11940-002-0024-2